BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol. 1992;128:702. [PMID: 1575541 DOI: 10.1001/archderm.1992.01680150136027] [Cited by in Crossref: 96] [Cited by in F6Publishing: 76] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Waśkiel A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Trichoscopy of alopecia areata: An update. J Dermatol 2018;45:692-700. [DOI: 10.1111/1346-8138.14283] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 9.3] [Reference Citation Analysis]
2 Bokhari L, Sinclair R. Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study. Int J Dermatol 2018;57:1464-70. [DOI: 10.1111/ijd.14192] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
3 Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14. [PMID: 12753387 DOI: 10.1034/j.1600-0749.2003.00032.x] [Cited by in Crossref: 402] [Cited by in F6Publishing: 302] [Article Influence: 23.6] [Reference Citation Analysis]
4 Ohlmeier MC, Traupe H, Luger TA, Böhm M. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design. J Eur Acad Dermatol Venereol 2012;26:503-7. [PMID: 21569118 DOI: 10.1111/j.1468-3083.2011.04114.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
5 Cruz AA, Akaishi PM, Vargas MA, de Paula SA. Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases. Ophthalmic Plast Reconstr Surg 2007;23:104-8. [PMID: 17413622 DOI: 10.1097/IOP.0b013e318030b06b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
6 Yang D, Zheng J, Zhang Y, Jin Y, Gan C, Bai Y. Total glucosides of paeony capsule plus compound glycyrrhizin tablets for the treatment of severe alopecia areata in children: a randomized controlled trial. Evid Based Complement Alternat Med 2013;2013:378219. [PMID: 24204391 DOI: 10.1155/2013/378219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
7 Richard M, Corgibet F, Beylot‐barry M, Barbaud A, Bodemer C, Chaussade V, D'incan M, Joly P, Leccia M, Meurant J, Petit A, Geffroy BR, Sei J, Taieb C, Misery L, Ezzedine K. Sex‐ and age‐adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study. J Eur Acad Dermatol Venereol 2018;32:1967-71. [DOI: 10.1111/jdv.14959] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 11.7] [Reference Citation Analysis]
8 Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata. Journal of the American Academy of Dermatology 2018;78:1-12. [DOI: 10.1016/j.jaad.2017.04.1141] [Cited by in Crossref: 108] [Cited by in F6Publishing: 75] [Article Influence: 36.0] [Reference Citation Analysis]
9 Sehgal VN, Jain S. Alopecia Areata: Clinical Perspective and an Insight into Pathogenesis. The Journal of Dermatology 2003;30:271-89. [DOI: 10.1111/j.1346-8138.2003.tb00389.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Islam N, Leung PS, Huntley AC, Eric Gershwin M. The autoimmune basis of alopecia areata: A comprehensive review. Autoimmunity Reviews 2015;14:81-9. [DOI: 10.1016/j.autrev.2014.10.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 13.7] [Reference Citation Analysis]
11 Patsner B, Harti S. A Botanical Compound for the Treatment of Alopecia Areata and Chemotherapy-Induced Alopecia. Journal of Investigative Dermatology Symposium Proceedings 2020;20:S69-70. [DOI: 10.1016/j.jisp.2020.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Burns LJ, Mesinkovska N, Kranz D, Ellison A, Senna MM. Cumulative Life Course Impairment of Alopecia Areata. Int J Trichology 2020;12:197-204. [PMID: 33531741 DOI: 10.4103/ijt.ijt_99_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. Journal of Dermatological Treatment. [DOI: 10.1080/09546634.2020.1773384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
14 Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol 2020;82:675-82. [PMID: 31437543 DOI: 10.1016/j.jaad.2019.08.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
15 Harrison S, Sinclair R. Optimal Management of Hair Loss (Alopecia) in Children: . American Journal of Clinical Dermatology 2003;4:757-70. [DOI: 10.2165/00128071-200304110-00004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
16 Benigno M, Anastassopoulos KP, Mostaghimi A, Udall M, Daniel SR, Cappelleri JC, Chander P, Wahl PM, Lapthorn J, Kauffman L, Chen L, Peeva E. A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States. Clin Cosmet Investig Dermatol 2020;13:259-66. [PMID: 32280257 DOI: 10.2147/CCID.S245649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo: Autoimmune epidemiology of familial vitiligo. Pigment Cell Research 2005;18:300-5. [DOI: 10.1111/j.1600-0749.2005.00242.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 98] [Article Influence: 7.2] [Reference Citation Analysis]
18 Li Y, Kilani RT, Pakyari M, Leung G, Nabai L, Ghahary A. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice. J Cell Physiol 2018;233:2590-601. [PMID: 28777458 DOI: 10.1002/jcp.26134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Neuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, Flodman P, Zone JJ. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008;31:160-5. [PMID: 18692362 DOI: 10.1016/j.jaut.2008.06.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
20 Borcherding N, Crotts SB, Ortolan LS, Henderson N, Bormann NL, Jabbari A. A transcriptomic map of murine and human alopecia areata. JCI Insight 2020;5:137424. [PMID: 32453712 DOI: 10.1172/jci.insight.137424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Li DG, Huang KP, Xia FD, Joyce C, Scott DA, Qureshi AA, Mostaghimi A. Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO). PLoS One 2018;13:e0196517. [PMID: 29874239 DOI: 10.1371/journal.pone.0196517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Concepts of patients with alopecia areata about their disease. BMC Dermatol 2005;5:1. [PMID: 15644147 DOI: 10.1186/1471-5945-5-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
23 Lim SK, Lim CA, Kwon IS, Im M, Seo YJ, Kim CD, Lee JH, Lee Y. Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata. Ann Dermatol 2017;29:263-7. [PMID: 28566900 DOI: 10.5021/ad.2017.29.3.263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
24 Coda AB, Sinha AA. Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in Alopecia areata. Genomics 2011;98:431-9. [DOI: 10.1016/j.ygeno.2011.08.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
25 Trüeb RM, Dias MFRG. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management. Clin Rev Allergy Immunol 2018;54:68-87. [PMID: 28717940 DOI: 10.1007/s12016-017-8620-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
26 Sellami R, Masmoudi J, Ouali U, Mnif L, Amouri M, Turki H, Jaoua A. The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study. Indian J Dermatol 2014;59:421. [PMID: 25071275 DOI: 10.4103/0019-5154.135525] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
27 Haida Y, Ikeda S, Takagi A, Komiyama E, Mabuchi T, Ozawa A, Kulski JK, Inoko H, Oka A. Association analysis of the HLA-C gene in Japanese alopecia areata. Immunogenetics 2013;65:553-7. [DOI: 10.1007/s00251-013-0703-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
28 Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol. 2006;126:74-78. [PMID: 16417220 DOI: 10.1038/sj.jid.5700009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
29 Lee NR, Kim BK, Yoon NY, Lee SY, Ahn SY, Lee WS. Differences in Comorbidity Profiles between Early-Onset and Late-Onset Alopecia Areata Patients: A Retrospective Study of 871 Korean Patients. Ann Dermatol 2014;26:722-6. [PMID: 25473224 DOI: 10.5021/ad.2014.26.6.722] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
30 Lyakhovitsky A, Shemer A, Amichai B. Increased prevalence of thyroid disorders in patients with new onset alopecia areata. Australas J Dermatol 2015;56:103-6. [PMID: 25303421 DOI: 10.1111/ajd.12178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
31 Xu L, Liu KX, Senna MM. A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents. Front Med (Lausanne) 2017;4:112. [PMID: 28791288 DOI: 10.3389/fmed.2017.00112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
32 Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol 2015;8:397-403. [PMID: 26244028 DOI: 10.2147/CCID.S53985] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
33 Marahatta S, Agrawal S, Adhikari BR. Psychological Impact of Alopecia Areata. Dermatol Res Pract 2020;2020:8879343. [PMID: 33424962 DOI: 10.1155/2020/8879343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Zerbinati N, Esposito C, D'Este E, Calligaro A, Valsecchi R. Topical Immunotherapy of Alopecia Areata: A Large Retrospective Study. Dermatol Ther (Heidelb) 2018;8:101-10. [PMID: 29442292 DOI: 10.1007/s13555-018-0226-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
35 Yeo IK, Ko EJ, No YA, Lim ES, Park KY, Li K, Kim BJ, Seo SJ, Kim MN, Hong CK. Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata. Ann Dermatol 2015;27:676-81. [PMID: 26719635 DOI: 10.5021/ad.2015.27.6.676] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
36 Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia Areata: An Autoimmune Disease of Multiple Players. Immunotargets Ther 2021;10:299-312. [PMID: 34350136 DOI: 10.2147/ITT.S266409] [Reference Citation Analysis]
37 Muhaidat JM, Al-Qarqaz F, Khader Y, Alshiyab DM, Alkofahi H, Almalekh M. A Retrospective Comparative Study of Two Concentrations of Intralesional Triamcinolone Acetonide in the Treatment of Patchy Alopecia Areata on the Scalp. Clin Cosmet Investig Dermatol 2020;13:795-803. [PMID: 33173320 DOI: 10.2147/CCID.S280855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol. 2014;134:1141-1142. [PMID: 24202232 DOI: 10.1038/jid.2013.464] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]
39 Olsen EA, Kornacki D, Sun K, Hordinsky MK. Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study. J Am Acad Dermatol 2020;82:412-9. [PMID: 31622643 DOI: 10.1016/j.jaad.2019.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
40 Rehman F, Dogra N, Wani MA. Serum Vitamin D Levels and Alopecia Areata- A Hospital Based Case-Control Study from North-India. Int J Trichology 2019;11:49-57. [PMID: 31007473 DOI: 10.4103/ijt.ijt_3_19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
41 Hayran Y, Gunindi Korkut M, Öktem A, Şen O, Gür Aksoy G, Özmen F. Evaluation of HLA class I and HLA class II allele profile and its relationship with clinical features in patients with alopecia areata: a case-control study. J Dermatolog Treat 2021;:1-7. [PMID: 34057862 DOI: 10.1080/09546634.2021.1937478] [Reference Citation Analysis]
42 Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers 2017;3:17011. [PMID: 28300084 DOI: 10.1038/nrdp.2017.11] [Cited by in Crossref: 140] [Cited by in F6Publishing: 101] [Article Influence: 35.0] [Reference Citation Analysis]
43 Han TY, Lee JH, Noh TK, Choi MW, Yun JS, Lee KH, Bae JM. Alopecia areata and overt thyroid diseases: A nationwide population-based study. J Dermatol 2018;45:1411-7. [PMID: 30222206 DOI: 10.1111/1346-8138.14648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
44 Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549-566. [PMID: 10727299 DOI: 10.1067/mjd.2000.103909] [Cited by in Crossref: 188] [Cited by in F6Publishing: 93] [Article Influence: 9.0] [Reference Citation Analysis]
45 Rattananukrom T, Suchonwanit P. Are drug treatment strategies really effective against alopecia areata? Expert Opin Pharmacother 2021;22:257-60. [PMID: 33280456 DOI: 10.1080/14656566.2020.1854728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Kandpal R. Alopecia Universalis in a Case of Rheumatoid Arthritis after Treatment with Etanercept. Int J Trichology 2019;11:173-6. [PMID: 31523110 DOI: 10.4103/ijt.ijt_22_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Oltulu P, Oltulu R, Turk HB, Turk N, Kilinc F, Belviranli S, Mirza E, Ataseven A. The ocular surface findings in alopecia areata patients: clinical parameters and impression cytology. Int Ophthalmol 2021. [PMID: 34331623 DOI: 10.1007/s10792-021-01991-y] [Reference Citation Analysis]
48 Marchitto MC, Qureshi A, Marks D, Awosika O, Rengifo-Pardo M, Ehrlich A. Emerging Nonsteroid-Based Procedural Therapies for Alopecia Areata: A Systematic Review. Dermatol Surg 2019;45:1484-506. [PMID: 31403534 DOI: 10.1097/DSS.0000000000002053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Choi JW, Suh DW, Lew BL, Sim WY. Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients. Ann Dermatol 2017;29:755-60. [PMID: 29200765 DOI: 10.5021/ad.2017.29.6.755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
50 King B, Guttman-Yassky E, Peeva E, Banerjee A, Sinclair R, Pavel AB, Zhu L, Cox LA, Craiglow B, Chen L, Banfield C, Page K, Zhang W, Vincent MS. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results. J Am Acad Dermatol 2021;85:379-87. [PMID: 33757798 DOI: 10.1016/j.jaad.2021.03.050] [Reference Citation Analysis]
51 Phillips MA, Graves JE, Nunley JR. Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine. Journal of the American Academy of Dermatology 2005;53:S252-5. [DOI: 10.1016/j.jaad.2005.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
52 Shahidi-Dadras M, Bahraini N, Rajabi F, Younespour S. Patients with alopecia areata show signs of insulin resistance. Arch Dermatol Res 2019;311:529-33. [PMID: 31089876 DOI: 10.1007/s00403-019-01929-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Bolduc C, Bissonnette R. Safety and efficacy of adalimumab for the treatment of severe alopecia areata: case series of three patients. J Cutan Med Surg 2012;16:257-60. [PMID: 22784518 DOI: 10.1177/120347541201600407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
54 Guimarães LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res 2015;100:190-209. [PMID: 26275795 DOI: 10.1016/j.phrs.2015.08.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 10.7] [Reference Citation Analysis]
55 Hamilton CE, Craiglow BG. JAK Inhibitors for the Treatment of Pediatric Alopecia Areata. J Investig Dermatol Symp Proc. 2020;20:S31-S36. [PMID: 33099381 DOI: 10.1016/j.jisp.2020.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Paller AS, Varigos G, Metzker A, Bauer RC, Opie J, Martinez-Mir A, Christiano AM, Zlotogorski A. Compound heterozygous mutations in the hairless gene in atrichia with papular lesions. J Invest Dermatol 2003;121:430-2. [PMID: 12880440 DOI: 10.1046/j.1523-1747.2003.12370.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
57 Jahn-Bassler K, Bauer WM, Karlhofer F, Vossen MG, Stingl G. Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata. J Dtsch Dermatol Ges 2017;15:42-7. [PMID: 28140540 DOI: 10.1111/ddg.12875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70:628-633. [PMID: 7791384 DOI: 10.4065/70.7.628] [Cited by in Crossref: 315] [Cited by in F6Publishing: 255] [Article Influence: 12.1] [Reference Citation Analysis]
59 Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol 2012;166:525-31. [PMID: 22049923 DOI: 10.1111/j.1365-2133.2011.10714.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
60 Rivitti EA. Alopecia areata: revisão e atualização. An Bras Dermatol 2005;80:57-68. [DOI: 10.1590/s0365-05962005000100009] [Cited by in Crossref: 16] [Article Influence: 1.0] [Reference Citation Analysis]
61 Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. J Am Acad Dermatol 2016;74:295-302. [PMID: 26518171 DOI: 10.1016/j.jaad.2015.08.063] [Cited by in Crossref: 65] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
62 Coda AB, Qafalijaj Hysa V, Seiffert-Sinha K, Sinha AA. Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity. Genes Immun 2010;11:531-41. [PMID: 20535136 DOI: 10.1038/gene.2010.32] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
63 Kuldeep C, Singhal H, Khare AK, Mittal A, Gupta LK, Garg A. Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata. Int J Trichology 2011;3:20-4. [PMID: 21769231 DOI: 10.4103/0974-7753.82123] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
64 Terziroli Beretta-piccoli B, Invernizzi P, Gershwin ME, Mainetti C. Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review. Clinic Rev Allerg Immunol 2017;53:394-412. [DOI: 10.1007/s12016-017-8649-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
65 Wikramanayake TC, Rodriguez R, Choudhary S, Mauro LM, Nouri K, Schachner LA, Jimenez JJ. Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata. Lasers Med Sci 2012;27:431-6. [PMID: 21739260 DOI: 10.1007/s10103-011-0953-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
66 Lee H, Jung SJ, Patel AB, Thompson JM, Qureshi A, Cho E. Racial characteristics of alopecia areata in the United States. J Am Acad Dermatol 2020;83:1064-70. [PMID: 31279016 DOI: 10.1016/j.jaad.2019.06.1300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Thanomkitti K, Kanlaya R, Fong-Ngern K, Kapincharanon C, Sueksakit K, Chanchaem P, Thuangtong R, Thongboonkerd V. Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata. Sci Rep 2018;8:521. [PMID: 29323127 DOI: 10.1038/s41598-017-18282-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
68 Suzuki T, Tokura Y, Ito T. Similarities of dermoscopic findings in alopecia areata between human and C3H/HeJ mouse. Journal of Dermatological Science 2016;83:154-7. [DOI: 10.1016/j.jdermsci.2016.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Oh GN, Son SW. Efficacy of korean red ginseng in the treatment of alopecia areata. J Ginseng Res 2012;36:391-5. [PMID: 23717141 DOI: 10.5142/jgr.2012.36.4.391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
70 Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature. World J Clin Cases 2021;9:3741-51. [PMID: 34046478 DOI: 10.12998/wjcc.v9.i15.3741] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Tzur Bitan D, Berzin D, Kridin K, Cohen A. The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res 2021. [PMID: 34089375 DOI: 10.1007/s00403-021-02247-6] [Reference Citation Analysis]
72 Abenavoli L, Proietti I, Leggio L, Ferrulli A, Vonghia L, Capizzi R, Rotoli M, Amerio PL, Gasbarrini G, Addolorato G. Cutaneous manifestations in celiac disease. World J Gastroenterol 2006;12:843-52. [PMID: 16521210 DOI: 10.3748/wjg.v12.i6.843] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
73 Hill ND, Bunata K, Hebert AA. Treatment of alopecia areata with squaric acid dibutylester. Clin Dermatol 2015;33:300-4. [PMID: 25889130 DOI: 10.1016/j.clindermatol.2014.12.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
74 Żeberkiewicz M, Rudnicka L, Malejczyk J. Immunology of alopecia areata. Cent Eur J Immunol 2020;45:325-33. [PMID: 33437185 DOI: 10.5114/ceji.2020.101264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Li SF, Zhang XT, Qi SL, Ye YT, Cao H, Yang YQ, McElwee KJ, Zhang X. Allergy to dust mites may contribute to early onset and severity of alopecia areata. Clin Exp Dermatol. 2015;40:171-176. [PMID: 25252126 DOI: 10.1111/ced.12471] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
76 Jabbari A, Petukhova L, Cabral RM, Clynes R, Christiano AM. Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin 2013;31:109-17. [PMID: 23159180 DOI: 10.1016/j.det.2012.08.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]